In gastric cancer, higher expression of METTL3 is associated with poor prognosis, and mechanistically, METTL3 mediates the m6A modification of HDGF mRNA in a manner with IGF2BP3-dependent HDGF mRNA stability 187. The gene discussed is HDGF; the disease is gastric cancer.